Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.
about
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Combination of Autoantibody Si ...... Benign Prostatic Hyperplasia.
@ast
Combination of Autoantibody Si ...... Benign Prostatic Hyperplasia.
@en
type
label
Combination of Autoantibody Si ...... Benign Prostatic Hyperplasia.
@ast
Combination of Autoantibody Si ...... Benign Prostatic Hyperplasia.
@en
prefLabel
Combination of Autoantibody Si ...... Benign Prostatic Hyperplasia.
@ast
Combination of Autoantibody Si ...... Benign Prostatic Hyperplasia.
@en
P2093
P2860
P1433
P1476
Combination of Autoantibody Si ...... h Benign Prostatic Hyperplasia
@en
P2093
Andreas Keller
Angelika Werth
Bastian Keck
Bernd Wullich
Christian Harz
Eckart Meese
Hans-Peter Lenhof
Lisa Milchram
Martin Hart
Nicole Ludwig
P2860
P304
P356
10.1371/JOURNAL.PONE.0128235
P407
P577
2015-06-03T00:00:00Z